Concepts and challenges of biosimilars to mitigate the oncology drug expenses
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
| Κύριος συγγραφέας: | Tania, Umme |
|---|---|
| Άλλοι συγγραφείς: | Haque , Md. Aminul |
| Μορφή: | Thesis |
| Γλώσσα: | en_US |
| Έκδοση: |
Brac University
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | http://hdl.handle.net/10361/15111 |
Παρόμοια τεκμήρια
-
Biosimilar in lymphoma treatment
ανά: Tanisha, Mehrin Haque
Έκδοση: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
ανά: Tabassum, Turana
Έκδοση: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
ανά: Tania, Umme
Έκδοση: (2023) -
Advancement of Antibody-Drug conjugates in cancer treatment: A review
ανά: Sagar, Baejid Hossain
Έκδοση: (2022) -
Immunotherapeutic approaches to treat cancer: Prospects and challenges
ανά: Fred, Namanda Rogers
Έκδοση: (2021)